Switzerland · Biotechnology startup
Switzerland · CorFlow Therapeutics AG
CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions.
Funding reportedLast round: Series A
What company datasets say CorFlow Therapeutics AG raised
Funding, as reported
Reported in all48.5Min the source's currency
Rounds4
Last roundSeries A
Last round dateMar 2021
Investors listed5
Founders and team
From CorFlow Therapeutics AG's own website: 11 on the team.
- Pedro EerdmansVice President, Clinical
- Paul G. MeadCEO
- Duraid AntoneCOO
- Reeder BeksCFO
- Emma van EedenHead of Medical Affairs and Market Development
- Lukas BereuterHead of Product Development
- Markus BütlerHead of Quality
- Oliver BludauHead of Operations and Supplier Engineering
- Reggie WaltonHead of US Clinical Operations
- Chris O'ConnellChairman
- Rick GeoffrionDirector, representing 415C
On 5 portfolio pages
Investors who name them
KOFA Healthcare Investments
Laerdal Million Lives Fund
Longview Ventures
Merieux Equity Partners
Valiance Asset Management
Each firm lists CorFlow Therapeutics AG on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biotechnology in Switzerland
Startups like it
Is this your company?
Add your raise, your deck and your story, and put CorFlow Therapeutics AG in front of investors. Or tell us what we have wrong.